The stock of Pediatrix Medical Group Inc (NYSE: MD) has increased by 1.79 when compared to last closing price of 14.49.Despite this, the company has seen a loss of -0.07% in its stock price over the last five trading days. zacks.com reported 2024-11-08 that If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our ‘Fast-Paced Momentum at a Bargain’ screen.
Is It Worth Investing in Pediatrix Medical Group Inc (NYSE: MD) Right Now?
Additionally, the 36-month beta value for MD is 1.55. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 10 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MD is 84.71M and currently, short sellers hold a 4.66% ratio of that float. The average trading volume of MD on November 22, 2024 was 656.92K shares.
MD’s Market Performance
MD stock saw an increase of -0.07% in the past week, with a monthly gain of 17.53% and a quarterly increase of 30.42%. The volatility ratio for the week is 3.49%, and the volatility levels for the last 30 days are 4.02% for Pediatrix Medical Group Inc (MD). The simple moving average for the past 20 days is 1.47% for MD’s stock, with a 50.77% simple moving average for the past 200 days.
Analysts’ Opinion of MD
Many brokerage firms have already submitted their reports for MD stocks, with Jefferies repeating the rating for MD by listing it as a “Buy.” The predicted price for MD in the upcoming period, according to Jefferies is $14 based on the research report published on September 26, 2024 of the current year 2024.
Deutsche Bank, on the other hand, stated in their research note that they expect to see MD reach a price target of $8. The rating they have provided for MD stocks is “Hold” according to the report published on June 07th, 2024.
SVB Leerink gave a rating of “Mkt Perform” to MD, setting the target price at $29 in the report published on September 27th of the previous year.
MD Trading at 14.82% from the 50-Day Moving Average
After a stumble in the market that brought MD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.12% of loss for the given period.
Volatility was left at 4.02%, however, over the last 30 days, the volatility rate increased by 3.49%, as shares surge +17.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.83% upper at present.
During the last 5 trading sessions, MD fell by -0.07%, which changed the moving average for the period of 200-days by +65.92% in comparison to the 20-day moving average, which settled at $14.54. In addition, Pediatrix Medical Group Inc saw 58.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MD starting from ORDAN MARK S, who sale 27,600 shares at the price of $15.35 back on Nov 13 ’24. After this action, ORDAN MARK S now owns 138,683 shares of Pediatrix Medical Group Inc, valued at $423,660 using the latest closing price.
ORDAN MARK S, the Director of Pediatrix Medical Group Inc, proposed sale 27,600 shares at $15.50 during a trade that took place back on Nov 13 ’24, which means that ORDAN MARK S is holding shares at $427,800 based on the most recent closing price.
Stock Fundamentals for MD
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.2 for the gross margin
The net margin for Pediatrix Medical Group Inc stands at -0.13. The total capital return value is set at -0.0. Equity return is now at value -29.85, with -11.53 for asset returns.
Based on Pediatrix Medical Group Inc (MD), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 0.88. The interest coverage ratio of the stock is -0.11.
Currently, EBITDA for the company is 29.89 million with net debt to EBITDA at -3.02. When we switch over and look at the enterprise to sales, we see a ratio of 0.92. The receivables turnover for the company is 6.97for trailing twelve months and the total asset turnover is 0.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.42.
Conclusion
In conclusion, Pediatrix Medical Group Inc (MD) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
